Cargando…

Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage

Candida albicans is a pathobiont of the gastrointestinal tract. It can contribute to the diversity of the gut microbiome without causing harmful effects. When the immune system is compromised, C. albicans can damage intestinal cells and cause invasive disease. We hypothesize that a therapeutic appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebai, Yasmine, Wagner, Lysett, Gnaien, Mayssa, Hammer, Merle L., Kapitan, Mario, Niemiec, Maria Joanna, Mami, Wael, Mosbah, Amor, Messadi, Erij, Mardassi, Helmi, Vylkova, Slavena, Jacobsen, Ilse D., Znaidi, Sadri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457924/ https://www.ncbi.nlm.nih.gov/pubmed/37630490 http://dx.doi.org/10.3390/microorganisms11081929

Ejemplares similares

High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
por: Messaoud, Mariem, et al.
Publicado: (2021)

Inflammatory Bowel Disease Increases the Severity of Myocardial Infarction after Acute Ischemia–Reperfusion Injury in Mice
por: Mami, Wael, et al.
Publicado: (2023)

The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides
por: Vylkova, Slavena, et al.
Publicado: (2007)

Active neutrophil responses counteract Candida albicans burn wound infection of ex vivo human skin explants
por: von Müller, Christin, et al.
Publicado: (2020)

Functional analysis of the Candida albicans ECE1 Promoter
por: Garbe, Enrico, et al.
Publicado: (2023)

Modulation of Phagosomal pH by Candida albicans Promotes Hyphal Morphogenesis and Requires Stp2p, a Regulator of Amino Acid Transport
por: Vylkova, Slavena, et al.
Publicado: (2014)

Bloodstream infection due to Enterobacter ludwigii, correlating with massive aggregation on the surface of a central venous catheter
por: Wagner, Lysett, et al.
Publicado: (2020)

Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity
por: Alonso-Roman, Raquel, et al.
Publicado: (2022)

The Fungal Pathogen Candida albicans Autoinduces Hyphal Morphogenesis by Raising Extracellular pH
por: Vylkova, Slavena, et al.
Publicado: (2011)

Clinical Candida albicans Vaginal Isolates and a Laboratory Strain Show Divergent Behaviors during Macrophage Interactions
por: Gerwien, Franziska, et al.
Publicado: (2020)

Candida albicans SR-Like Protein Kinases Regulate Different Cellular Processes: Sky1 Is Involved in Control of Ion Homeostasis, While Sky2 Is Important for Dipeptide Utilization
por: Brandt, Philipp, et al.
Publicado: (2022)

Robust Extracellular pH Modulation by Candida albicans during Growth in Carboxylic Acids
por: Danhof, Heather A., et al.
Publicado: (2016)

Impaired amino acid uptake leads to global metabolic imbalance of Candida albicans biofilms
por: Böttcher, Bettina, et al.
Publicado: (2022)

GNP2 Encodes a High-Specificity Proline Permease in Candida albicans
por: Garbe, Enrico, et al.
Publicado: (2022)

Systematic Metabolic Profiling Identifies De Novo Sphingolipid Synthesis as Hypha Associated and Essential for Candida albicans Filamentation
por: Garbe, Enrico, et al.
Publicado: (2022)

S7.4d Candida albicans SR-like protein kinases regulate different cellular processes: Sky1 is involved in thecontrol of ion homeostasis, while Sky2 is important for dipeptide utilization
por: Brandt, Philipp, et al.
Publicado: (2022)

The Transcription Factor Stp2 Is Important for Candida albicans Biofilm Establishment and Sustainability
por: Böttcher, Bettina, et al.
Publicado: (2020)

Integrated analysis of SR-like protein kinases Sky1 and Sky2 links signaling networks with transcriptional regulation in Candida albicans
por: Luther, Christian H., et al.
Publicado: (2023)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Natriuretic-like Peptide Lebetin 2 Mediates M2 Macrophage Polarization in LPS-Activated RAW264.7 Cells in an IL-10-Dependent Manner
por: Bouzazi, Dorsaf, et al.
Publicado: (2023)

Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans
por: Delarze, Eric, et al.
Publicado: (2020)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

A Comprehensive Functional Portrait of Two Heat Shock Factor-Type Transcriptional Regulators Involved in Candida albicans Morphogenesis and Virulence
por: Znaidi, Sadri, et al.
Publicado: (2013)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
por: Liu, Qingyao, et al.
Publicado: (2021)

Functional Portrait of Irf1 (Orf19.217), a Regulator of Morphogenesis and Iron Homeostasis in Candida albicans
por: van Wijlick, Lasse, et al.
Publicado: (2022)

A conserved fungal hub protein involved in adhesion and drug resistance in the human pathogen Candida albicans
por: Martin-Yken, Hélène, et al.
Publicado: (2018)

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells
por: Schierack, Peter, et al.
Publicado: (2011)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018)

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity
por: Mooren, F. C., et al.
Publicado: (2020)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019)

No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests
por: Dubbert, Silke, et al.
Publicado: (2020)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_do3d6vqf5p4lggg20l5vjmq2jv